Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy.

Br J Cancer · 2018 · PMC5959932 · PMID 29755118

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significancep = 0.3not close (p > 0.1)

In the univariate Cox proportional hazards regression model, patients with either a BRAF or NRAS mutant tumour had an increased risk of developing recurrence following a negative SLNB compared to patients with wild-type tumours (HR = 1.40); however, unadjusted, this did not reach statistical significance (95% CI 0.76–2.59, p = 0.3).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.